Home › Funds › CIBRA Capital Ltd › FOLD

CIBRA Capital Ltd position in FOLD

AMICUS THERAPEUTICS INC

CIBRA Capital Ltd reported holding 1,687,661 shares of FOLD (AMICUS THERAPEUTICS INC) in its Q1 2026 13F filing — a position valued at US$24.4M, representing 11.78% of its reported portfolio and ranking #1 among its reported holdings. CIBRA Capital Ltd has disclosed FOLD holdings in 2 of the last 2 reported quarters, going back to Q4 2025.

Latest position (Q1 2026)1.69M sh
Reported value held$24.40M
Portfolio Weight11.78%
First reportedQ4 2025
Last changeAdd
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How CIBRA Capital Ltd's FOLD position evolved

CIBRA Capital Ltd first disclosed a stake in FOLD in Q4 2025 at 210,800 shares (US$3.0M). The position peaked in Q1 2026 at 1,687,661 shares, worth US$24.4M. Across 2 filings, CIBRA Capital Ltd increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2026) shows 1,687,661 shares valued at US$24.4M — an increase of 1,476,861 shares quarter over quarter.. Notable position changes include a 701% increase in Q1 2026.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 210.80K $3.00M New
Q1 2026 1.69M $24.40M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About FOLD and 13F data

FOLD (AMICUS THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 2 other funds we track also report a position in FOLD. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding FOLD

No other tracked fund reports a position in FOLD.

All FOLD fund holders →

FAQ

How long has CIBRA Capital Ltd held FOLD?

CIBRA Capital Ltd has disclosed FOLD holdings in 2 of the last 2 reported quarters, going back to Q4 2025.

What is CIBRA Capital Ltd's current position in FOLD?

As of Q1 2026, CIBRA Capital Ltd holds 1.69M shares of FOLD (AMICUS THERAPEUTICS INC), valued at $24.40M, representing 11.78% of its reported portfolio and ranking #1.

Has CIBRA Capital Ltd been buying or selling FOLD?

In the latest 13F filing (Q1 2026), CIBRA Capital Ltd increased its position in FOLD. The position peaked in Q1 2026 at 1.69M shares.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.